Our results showed that the PRS group was characterized by a decrease of claudin-1, ZO-1 and occludin expression compared to the control group, while the pre-treatment with XG and PP was able to restore their expression almost to basal levels thanks to their muco-adhesive and filming properties exercise on the barrier intestinal. The gene discussed is TJP1; the disease is polygenic risk score.